Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Relex Expands Into Health

Relex
Posted on: 28 Feb 18
Relex Expands Into Health

PR Newswire

NEW YORK, February 28, 2018

NEW YORK, February 28, 2018 /PRNewswire/ --

Relex, the blockchain investment channel, has announced a fund raising contract for further development and expansion of Aura inhalable health supplements. The New York-based Aura Inhale has just released inhalable CBD and Viagra. The company is seeking finance to fund further product development and worldwide expansion.

     (Logo: https://mma.prnewswire.com/media/635913/Relex_Logo.jpg )

The new agreement reached by Relex CEO Keith Hilden and Aura CFO Peter Alcure builds on a relationship between Aura and Relex parent Squawk Advisors Inc since 2015.

Aura's existing range sold in the U.S. includes energy, focus, memory, sleep, and anti-hangover supplements.

"This is the world's first inhalable pharmaceutical and supplement research and development to be funded by blockchain and cryptocurrency," Hilden said.

Relex will launch a new token for its health division to fund this venture, and holders of the original RLX, geared to real estate development, will be rewarded with a free bonus of RLX health tokens on a 1 for 1 basis.

Aura's chief scientist was the first to discover and patent the technology of inhalable Vitamin B and has gone on to develop an array of inhalable supplements and pharmaceuticals.

"We possess great competitive advantages in these products potencies, and we have a fast track for development to market for new inhalables," said Alcure.

Relex have also engaged a Philadelphia area strategy firm in order to solidify their FINRA and SEC approval strategy. The company is already indexed with the SEC's registration system, and is moving towards regulatory approval in order to utilize crowdfunding solutions for the real estate developers signed onto the Relex platform. Currently, real estate development units are available for direct purchase through the Relex platform, with crowdfunded ownership available upon FINRA approval.

"FINRA and SEC approval are important as the firm expands," said Hilden. 

Regulatory approval is a key differentiator between that approach and their cryptocurrency company competitors that invest in real estate.

Relex (RLX) tokens are traded on cryptocurrency exchanges including stocks.exchange,

Forkdelta, Etherdelta, and the new Singapore-based Nebula.exchange with more on the way.

FOR More Information contact: John Bonar, jbonar@yes-to-business.com Tel +44-773006533

SOURCE Relex

PR Newswire
www.prnewswire.com

Last updated on: 28/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.